Web Analytics Made Easy - StatCounter

Tetanus Toxoid Injection Tenders

Get complete information related to latest Tetanus Toxoid Injection Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Tetanus Toxoid Injection Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Tetanus Toxoid Injection Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

Central Government/Public Sector

CTN :40946765 Due date: 16 Jul, 202516 Jul, 2025 NA
Tender For corrigendum : supply of glulisine insulin analog rapid acting 100iu inj. -3ml cartridge ]

CTN :41053619 Due date: 18 Jul, 202518 Jul, 2025 NA
Tender For supply of insulin glulisine 100iu/ml inj 3ml cartridge [ warranty period: 30 months after the dat e of delivery ]

CTN :40996553 Due date: 17 Jul, 202517 Jul, 2025 NA
Tender For supply of inj human insuline glulisine 100 iu/ml rdna 3ml pfp .quote.its brand name formu lation life product image . [ warranty period: 30 months after the date of delivery ]

Central Government/Public Sector

CTN :40423053 Due date: 19 Jul, 202519 Jul, 2025 31.63 Crore
Tender For corrigendum : supply of drugs under group no 13. - anti-tetanus immunoglobulin injection 250 iu, 1 ml vial., anti-d immunoglobulin injection 300 mcg, 2 ml vial, diphtheria antitoxin injection 10000 iu, 10 ml vial, hepatitis b immunoglobulin injection 100 iu , 1 ml vial, human normal immunoglobulin injection 5%, 100 ml vial, rabies anti serum ip (equine) 300 units per ml contains equine anti-rabies immunoglobulin fragnents (im/sc use)., 5 ml vial, rabies vaccine injection 2.5 iu , vial with 1 ml sterile water for injection, tetanus toxoid injection 0.5 ml, amp

Corporations And Associations And Others

CTN :40950061 Due date: 25 Jul, 202525 Jul, 2025 36.45 Crore
Tender For online tender for the rate contract for the supply of medicines to various hospitals of government of haryana for a period of two years for group a medicines - paracetamol tablet 500 mg, diclofenac + paracetamol tablet 50mg+325mg, framycetin cream 1%, 30 gm tube, normal saline (sodium chloride) injection 0.9% w/v, 500 ml bottle ( ffs technology), ringer lactate (solution ) for injection ( compound sodium lactate) 500 ml ffs bottle, amoxicillin + clavulanic acid injection 1.2 gm, 10 ml vial with diluents, dextrose 5 % w/v with sodium chloride 0.9% w/v for intravenous infusion 500 ml ffs bottle, plasma volume expander injection (each 100 ml contains polygeline, polypeptides of degaraded gelatin, cross linked via urea bridges 3.5 g (equivalent to 0.63 g of nitrogen) nacl ip 0.85 g, kcl ip 0.038 g cacl2 ip 0.070g water for injection ip q.s electrolytes in m.mol/litre, 500 ml ffs, levofloxacin tablet 500 mg, dextrose intravenous infusion ip 5 % w/v, 500 ml ffs bottle, aceclofenac tablet 100 mg, hydrocortisone ( sodium sucinate powder) injection 100 mg vial, with 2 ml distilled water for reconstitution, nitrofurantoin capsule 100 mg, clotrimazole pessaries 200 mg, ciprofloxacin injection 2mg/ml, 100 ml bottle for infusion ffs technology, multi electrolyte injection (isolyte p multiple electrolyte & dextrose injection type 1 ), 500 ml ffs bottle, ondansetron injection 2mg/ml, 2ml ampoule, acetylsalicylic acid tablet 75 mg gastro-resistant (enteric coated/ delayed release), paracetamol infusion 100 mg/10 ml, 100 ml bottle ffs technology, biphasic isophane injection 40 i.u/ml, (30/70), 10 ml vial, multi vitamin infusion 10 ml: each ml contains vitamin a (as vitamin a concentrate oily form) lp 1100 lu, cholecalciferol lp 100 lu, tocopheryl acetate lp 0.5mg, nicotinamide lp 10mg, riboflavin sodium phosphate lp 1.4mg, pyridoxine hydrochloride lp 1.65mg, thiamine hydrochloride lp 5.0mg, ascorbic acid ip 50.0mg, l-cysteine hydrochloride usp 0.2mg, benzyl alcohol (as preservative) lp 1.0% v/v, water for injections lp q.s, hepatitis b immunoglobulin injection 100 iu, 1 ml vial, dextrose intravenus infusion ip 10% w/v, 500 ml ffs bottle, cefotaxime injection 500 mg 5 ml vial with diluent, lignocaine injection 2%, 30 ml vial, ferrous (iron sucrose) injection 20 mg/ml, tramadol hydrochloride capsule 100 mg, dextrose intravenous infusion ip 25% w/v, 100 ml ffs bottle, lignocaine hydrochloride and adrenaline bitartarate injection 20mg/ml and 0.01mg/ml adrenaline, 30 ml vial, phenytoin (sodium) injection 100mg, 2ml amp., ceftriaxone injection 250 mg 2 ml vial with diluent, methyl prednisolone injection 1gm, 1 gm vial with diluent, ampicillin sodium injection 500mg 2 ml vial with diluent, normal saline injection 3%, adrenaline injection 1 mg/ml, 1:1000, 1 ml amp, amoxicillin + clavulanic acid injection 250 mg +50 mg, vial with diluents, isoflurane inhalation 100 ml vial, magnesium sulphate injection 1 gm /2ml (50%w/v), 2 ml ampoule, thiamine injection 100 mg/ml, 2 ml vial, paracetamol injection 150 mg/ml, 2 ml amp., ketamine (as hydrochloride) injection 50 mg /ml,10 ml vial, propofol injection 1% vial (10 mg/ml, 10 ml vial), isoxsuprine injection 5 mg/ ml, 2ml ampoule, adenosine injection 3 mg/ ml, 1 ml ampoule, magnesium sulphate injection 2.5 gm /5ml(50%w/v), 5 ml ampoule, potassium chloride (solution) injectable 15% (150mg/ml), 10 ml amp., hydroxycobalamin injection 1 mg/ ml, diazepam injection 5 mg/ml, 2 ml ampoule, aminophylline injection 25 mg/ ml, 10 ml ampoule, dobutamine injection 250mg/5ml, methyl ergometrine injection 200 mcg in 1 ml ampoule, torasemide tablet 10 mg, tetanus toxoid injection 0.5 ml ampoule, etophylline + theophylline injection 169.4 mg + 50.6 mg/2 ml ampoule, ciprofloxacin ophthalmic ointment 0.3% 5 gm tube, albendazole chewable tablets 400 mg(the chewable tablets shall also comply with the test for disintegration and dissolution as per monograph given in international pharmacopeia as per requirement of goi)

Central Government/Public Sector

CTN :40932053 Due date: 15 Jul, 202515 Jul, 2025 NA
Tender For supply of insulin glulisine injection (monocomponent insulin glulisine) 100 units/ml inj ection/pfs/catridge (one pen and 50 needle free with 50 cartridge) ]

CTN :40855862 Due date: 17 Jul, 202517 Jul, 2025 NA
Tender For supply of inj iron succinate fractionate dextran 100 mg , oint clobetasol gm , inj insulin glulisine 100iu per ml3ml pfs , eye drop ciprofloxacin 0 point 3 percent 3mg per ml bott of 5ml , oint ketoconazole 2 percent 30 g tube , desensitizing paste sensodent , halobetasol oint , halobetasol plus salicylic acid oint

Central Government/Public Sector

CTN :40866800 Due date: 17 Jul, 202517 Jul, 2025 NA
Tender For supply of insulin glulisine injection (monocomponent insulin glulisine) 100 units/ml inj ection/pfs/catridge ]

Central Government/Public Sector

CTN :40851095 Due date: 08 Aug, 202508 Aug, 2025 NA
Tender For supply of inj. insulin glulisine (monocomponent insulin glulisine) 100 units/ml, pfs/cartrid ge (one pen & 50 needles free with 50 cartridges) per unit (item no. 2100 of ami 2025-26) (bran d - apidra, marketed by m/s. sanofi india limited) ]
 Loading, Please wait...

Connect us via What's Up